Original Research

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia

Hagberg KW, Divan HA, Fang SC, Nickel JC, Jick SS

Clinical Epidemiology 2017, 9:83-91

Published Date: 10 February 2017